Mikael Kubista

Last updated
Prof. Mikael Kubista
Mikael face cut.png
Born (1961-08-13) 13 August 1961 (age 62)
NationalitySwedish
CitizenshipSwedish
Alma mater
Known for
  • quantitative real-time PCR (qPCR)
  • TAATA Bio-center
Awards
  • In 2012, Pioneer of the year in western Sweden
  • In 1996, won Innovation Cup in western Sweden for the LightUp probes
Scientific career
FieldsBiochemistry
Institutions

Mikael Kubista (born 13 August 1961) is Czech-born Swedish chemist and entrepreneur who works in the field of molecular diagnostics. Since 2007, he is serving as a Professor of Chemistry and Head of the Department of Gene Expression Profiling at the Biotechnology Institute, Czech Academy of Sciences in the Czech Republic.

Contents

Kubista has contributed to the field of quantitative real-time PCR (qPCR), with his work recognized as part of the early research in this area. [1] [2] [3] [ dubious discuss ]

Kubista was a member of the research team at Astra Hässle, where they focused on investigating Omeprazole, an inhibitor of K+/H+-ATPase. The drug is now marketed under the trade names Losec and Nexium, widely prescribed medications for the treatment of gastric ulcer. [4] [ dubious discuss ] Additionally, Kubista is the Chairman of the Board of MultiD Analyses AB and the founder of TATAA Biocenter. [5] [6] [7] [8]

Early life

Kubista was born to his medical doctor father in the former Czechoslovakia in 1961. His father received a scholarship and relocated to Sweden. At the age of 7 in 1968, Kubista went to Sweden to visit his father. However, on that very day, Russia invaded Czechoslovakia in the so called Warsaw Pact invasion of Czechoslovakia, and as a result, the family decided to stay making Sweden their new home. [9]

Education

He completed his undergraduate studies at University of Gothenburg, earning a B.Sc. degree in chemistry in 1984. [10] He then pursued a Licentiate in Physical Chemistry at the Institute of Chemistry and Chemical Engineering, Chalmers University of Technology in Göteborg, which he completed in 1986. [11] Kubista obtained his Ph.D. in chemistry from Chalmers University of Technology. [12] Following his doctoral studies, he conducted postdoctoral research at institutions such as La Trobe University in Melbourne, Australia, and Yale University in New Haven, US. [8] [4] [ dubious discuss ] Additionally, he has held visiting professor positions at various universities, including the University of Maryland in College Park, US, in June 2000, and the University of A Coruña in Spain, during September–November 2003 and July 2006 to June 2007.[ citation needed ] Since 2007, Kubista is serving as an adjunct professor at the Institute of Biotechnology, Czech Academy of Sciences. [13] [14] [ dubious discuss ] [9]

Career

Academic career

Photo Kubista.jpg

Kubista began his academic career in 1991 as an Assistant Professor in the Department of Physical Chemistry at Chalmers University of Technology.[ citation needed ] From 1993 to 1997, he served as an Associate Professor in the Department of Biochemistry at the same institution. Following this, he held the position of Professor in the Department of Biochemistry at Chalmers University of Technology from 1997 to 2006.[ citation needed ] Since 2007, he is the Head of the Department of Gene Expression at the Institute of Biotechnology, BIOCEV, Czech Academy of Sciences. [15]

Entrepreneurial activities

TATAA Biocenter starting to give the first COVID Tests Covidtest Lasse + Micke.jpg
TATAA Biocenter starting to give the first COVID Tests

In 1998 Kubista founded LightUp Technologies AB after his research finding of lightUp probes, [2] a company that specializes in the development of real-time PCR tests for human infectious diseases. [16] [5] Three years later In 2001, Kubista's research led to the establishments of MultiD Analyses AB, which develops GenEx software for gene expression data analysis and TATAA Biocenter for qPCR and gene expression analysis. [16] [5] The company became known for its qPCR training services globally and its provision of qPCR services, particularly in Europe. TATAA Biocenter was the first laboratory in Europe to obtain flexible ISO 17025 accreditation and also was the first to provide COVID tests at the onset of the pandemic. [17] In 2014 Kubista implemented non-invasive prenatal testing (NIPT) in Sweden and subsequently founded Life Genomics AB. [5] In 2020, Kubista co-founded SimSen Diagnostics, a company focused on developing technology for liquid biopsy analyses. [8] [4] [18] [6]

Advisorial roles and memberships

Kubista holds several positions and advisory roles within the scientific and biotechnology communities including: Roche, ThermoFisher, Qiagen, Bio-Rad, and RealSeq Biosciences. He is also a member of the Scientific Advisory Council of Genetic Engineering News. [19] [1]

Kubista has also been involved in the establishment of modern molecular diagnostics in developing countries. Since 1999, he has served as an advisor to UNESCO, providing guidance and assistance to countries such as: Libya , Egypt, Iran, Grenada, and Ghana. [4] [9]

Kubista is an expert advisor for the European Commission Research Directorate General. Kubista advises the United Nations Educational Scientific and Cultural Organization (UNESCO) and is part of the scientific advisory board for the International Biotechnology Research in Tripoli, Libya, under UNESCO. [9] [20] [21]

Selected findings and publications

Two-tailed schematic Two-tailed schematic.jpg
Two-tailed schematic

Awards and recognition

Mikael Kubista receiving the Frost and Sulvian Award Frost sullivan.jpg
Mikael Kubista receiving the Frost and Sulvian Award


Related Research Articles

Molecular biology is a branch of biology that seeks to understand the molecular basis of biological activity in and between cells, including biomolecular synthesis, modification, mechanisms, and interactions.

Oligonucleotides are short DNA or RNA molecules, oligomers, that have a wide range of applications in genetic testing, research, and forensics. Commonly made in the laboratory by solid-phase chemical synthesis, these small fragments of nucleic acids can be manufactured as single-stranded molecules with any user-specified sequence, and so are vital for artificial gene synthesis, polymerase chain reaction (PCR), DNA sequencing, molecular cloning and as molecular probes. In nature, oligonucleotides are usually found as small RNA molecules that function in the regulation of gene expression, or are degradation intermediates derived from the breakdown of larger nucleic acid molecules.

<span class="mw-page-title-main">Fluorescent tag</span>

In molecular biology and biotechnology, a fluorescent tag, also known as a fluorescent label or fluorescent probe, is a molecule that is attached chemically to aid in the detection of a biomolecule such as a protein, antibody, or amino acid. Generally, fluorescent tagging, or labeling, uses a reactive derivative of a fluorescent molecule known as a fluorophore. The fluorophore selectively binds to a specific region or functional group on the target molecule and can be attached chemically or biologically. Various labeling techniques such as enzymatic labeling, protein labeling, and genetic labeling are widely utilized. Ethidium bromide, fluorescein and green fluorescent protein are common tags. The most commonly labelled molecules are antibodies, proteins, amino acids and peptides which are then used as specific probes for detection of a particular target.

<span class="mw-page-title-main">Locked nucleic acid</span> Biological molecule

A locked nucleic acid (LNA), also known as bridged nucleic acid (BNA), and often referred to as inaccessible RNA, is a modified RNA nucleotide in which the ribose moiety is modified with an extra bridge connecting the 2' oxygen and 4' carbon. The bridge "locks" the ribose in the 3'-endo (North) conformation, which is often found in the A-form duplexes. This structure provides for increased stability against enzymatic degradation. LNA also offers improved specificity and affinity in base-pairing as a monomer or a constituent of an oligonucleotide. LNA nucleotides can be mixed with DNA or RNA residues in a oligonucleotide.

<span class="mw-page-title-main">Keratin 19</span> Protein-coding gene in the species Homo sapiens

Keratin, type I cytoskeletal 19 (Keratin-19)) also known as cytokeratin-19 (CK-19) is a 40 kDa protein that in humans is encoded by the KRT19 gene. Keratin-19 is a type I keratin.

In molecular biology, a hybridization probe (HP) is a fragment of DNA or RNA, usually 15–10000 nucleotides long, which can be radioactively or fluorescently labeled. HPs can be used to detect the presence of nucleotide sequences in analyzed RNA or DNA that are complementary to the sequence in the probe. The labeled probe is first denatured into single stranded DNA (ssDNA) and then hybridized to the target ssDNA or RNA immobilized on a membrane or in situ.

Cycling probe technology (CPT) is a molecular biological technique for detecting specific DNA sequences. CPT operates under isothermal conditions. In some applications, CPT offers an alternative to PCR. However, unlike PCR, CPT does not generate multiple copies of the target DNA itself, and the amplification of the signal is linear, in contrast to the exponential amplification of the target DNA in PCR. CPT uses a sequence specific chimeric probe which hybridizes to a complementary target DNA sequence and becomes a substrate for RNase H. Cleavage occurs at the RNA internucleotide linkages and results in dissociation of the probe from the target, thereby making it available for the next probe molecule. Integrated electrokinetic systems have been developed for use in CPT.

<span class="mw-page-title-main">Real-time polymerase chain reaction</span> Laboratory technique of molecular biology

A real-time polymerase chain reaction is a laboratory technique of molecular biology based on the polymerase chain reaction (PCR). It monitors the amplification of a targeted DNA molecule during the PCR, not at its end, as in conventional PCR. Real-time PCR can be used quantitatively and semi-quantitatively.

<span class="mw-page-title-main">SYBR Green I</span> Dye used for molecular genetics

SYBR Green I (SG) is an asymmetrical cyanine dye used as a nucleic acid stain in molecular biology. The SYBR family of dyes is produced by Molecular Probes Inc., now owned by Thermo Fisher Scientific. SYBR Green I binds to DNA. The resulting DNA-dye-complex best absorbs 497 nanometer blue light and emits green light. The stain preferentially binds to double-stranded DNA, but will stain single-stranded (ss) DNA with lower performance. SYBR Green can also stain RNA with a lower performance than ssDNA.

Digital polymerase chain reaction is a biotechnological refinement of conventional polymerase chain reaction methods that can be used to directly quantify and clonally amplify nucleic acids strands including DNA, cDNA, or RNA. The key difference between dPCR and qPCR lies in the method of measuring nucleic acids amounts, with the former being a more precise method than PCR, though also more prone to error in the hands of inexperienced users. PCR carries out one reaction per single sample. dPCR also carries out a single reaction within a sample, however the sample is separated into a large number of partitions and the reaction is carried out in each partition individually. This separation allows a more reliable collection and sensitive measurement of nucleic acid amounts. The method has been demonstrated as useful for studying variations in gene sequences — such as copy number variants and point mutations.

The RNA integrity number (RIN) is an algorithm for assigning integrity values to RNA measurements.

<span class="mw-page-title-main">Nucleic acid test</span> Group of techniques to detect a particular nucleic acid sequence

A nucleic acid test (NAT) is a technique used to detect a particular nucleic acid sequence and thus usually to detect and identify a particular species or subspecies of organism, often a virus or bacterium that acts as a pathogen in blood, tissue, urine, etc. NATs differ from other tests in that they detect genetic materials rather than antigens or antibodies. Detection of genetic materials allows an early diagnosis of a disease because the detection of antigens and/or antibodies requires time for them to start appearing in the bloodstream. Since the amount of a certain genetic material is usually very small, many NATs include a step that amplifies the genetic material—that is, makes many copies of it. Such NATs are called nucleic acid amplification tests (NAATs). There are several ways of amplification, including polymerase chain reaction (PCR), strand displacement assay (SDA), transcription mediated assay (TMA), and loop-mediated isothermal amplification (LAMP).

<span class="mw-page-title-main">History of polymerase chain reaction</span>

The history of the polymerase chain reaction (PCR) has variously been described as a classic "Eureka!" moment, or as an example of cooperative teamwork between disparate researchers. Following is a list of events before, during, and after its development:

OLIGO Primer Analysis Software is a software for DNA primer design. The first paper describing this software was published in 1989. The program is a real time PCR primer and probe search and analysis tool. It additionally performs siRNA and molecular beacon searches, open reading frame analysis, and restriction enzyme analysis. It was created and maintained by Wojciech Rychlik and Piotr Rychlik.

<span class="mw-page-title-main">MAGIChip</span>

MAGIChips, also known as "microarrays of gel-immobilized compounds on a chip" or "three-dimensional DNA microarrays", are devices for molecular hybridization produced by immobilizing oligonucleotides, DNA, enzymes, antibodies, and other compounds on a photopolymerized micromatrix of polyacrylamide gel pads of 100x100x20 μm or smaller size. This technology is used for analysis of nucleic acid hybridization, specific binding of DNA, and low-molecular weight compounds with proteins, and protein-protein interactions.

The FluoProbes series of fluorescent dyes were developed by Interchim to improve performances of standard fluorophores. They are designed for labeling biomolecules, cells, tissues or beads in advanced fluorescent detection techniques.

<span class="mw-page-title-main">SYBR Safe</span> DNA gel stain for molecular genetics

SYBR Safe is a cyanine dye used as a nucleic acid stain in molecular biology. SYBR Safe is one of a number of SYBR dyes made by the Life Technologies Corporation. SYBR Safe binds to DNA. The resulting DNA-dye-complex absorbs blue light and emits green light.

Tom Brown FRSC FRSE is a British chemist, biotechnologist, and entrepreneur. He is the Professor of Nucleic acid chemistry at the Department of Chemistry and Department of Oncology at the University of Oxford. Currently, he is serving as the President of the Chemical Biology Interface Division of the Royal Society of Chemistry. He is best known for his contribution in the field of DNA Repair, DNA Click chemistry, and in the application of Molecular genetics in forensics and diagnostics.

<span class="mw-page-title-main">Pernilla Wittung-Stafshede</span> Swedish biophysical chemist

Pernilla Wittung-Stafshede is a Swedish biophysical chemist, born in 1968, who is a professor of chemical biology at Chalmers University of Technology in Gothenburg. In 2019 she was named by International Union of Pure and Applied Chemistry as a Distinguished Woman in Chemistry.

The Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines are a set of protocols for conducting and reporting quantitative real-time PCR experiments and data, as devised by Bustin et al. in 2009. They were devised after a paper was published in 2002 that claimed to detect measles virus in children with autism through the use of RT-qPCR, but the results proved to be completely unreproducible by other scientists. The authors themselves also did not try to reproduce them and the raw data was found to have a large amount of errors and basic mistakes in analysis. This incident prompted Stephen Bustin to create the MIQE guidelines to provide a baseline level of quality for qPCR data published in scientific literature.

References

  1. 1 2 "Bringing qPCR testing into the 21st century: an interview with Mikael Kubista". thermofisher. 18 October 2019. Retrieved 28 December 2023.
  2. 1 2 3 "Biomolecular Detection and Quantification" (PDF). gene-quantification. Retrieved 2 January 2024.
  3. "Gene Core". ibt. Retrieved 22 February 2024.
  4. 1 2 3 4 5 "M. Kubista, PhD – Editorial Board – Molecular Aspects of Medicine – Journal – Elsevier". journals.elsevier.com. Retrieved 2023-12-28.
  5. 1 2 3 4 5 "Mikael Kubista". BioTech Pharma Summit. Retrieved 2023-12-28.
  6. 1 2 3 "TATAA Biocenter – ett av Sveriges snabbast växande teknikföretag". Mynewsdesk (in Swedish). 2021-11-19. Retrieved 2023-12-28.
  7. "What's next for Gothenburg life science profile, Mikael Kubista?". sahlgrenskasciencepark.se. Retrieved 2023-12-28.
  8. 1 2 3 "mikael-kubista". qiagen.com. Retrieved 2023-12-28.
  9. 1 2 3 4 Tachibana, Chris. "Profile, Mikael Kubista" (PDF). squarespace. Retrieved 2 January 2024.
  10. "GOTEBORGS UNIVERSITET". labgenexp9. Retrieved 8 March 2024.
  11. "GOTEBORGS uUNIVERSITET". labgenexp. Retrieved 8 March 2024.
  12. "CHALMERS TEKNISKA HOGSCOLA". labgenexp. Retrieved 8 March 2024.
  13. "Academy of Europe: CV". ae-info.org. Retrieved 2023-12-28.
  14. "Scientific Advisory Board". Technology Networks. Retrieved 2023-12-28.
  15. "Laboratory of Gene Expression". ibt. Retrieved 8 March 2024.
  16. 1 2 3 "Mikael Kubista". publicationslist. Retrieved 28 December 2023.
  17. "TATAA Biocenter to offer GLP services to developers of cell and gene therapies across the world". naringsliv. Retrieved 28 December 2023.
  18. "Who we are". simsendiagnostics. Retrieved 8 March 2024.
  19. "RealSeq: Mikael Kubista". 360dx. Retrieved 28 December 2023.
  20. 1 2 3 4 5 "Academy of Europe: Kubista Mikael". ae-info.org. Retrieved 2023-12-28.
  21. Göransson, Av Anders (2024-01-31). "Failed to read the fine print – lost his life's work". Life Science Sweden. Retrieved 2024-05-27.
  22. Sjöback, Robert; Nygren, Jan; Kubista, Mikael (1995). "Absorption and fluorescence properties of fluorescein". Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 51 (6): L7–L21. Bibcode:1995AcSpA..51L...7S. doi:10.1016/0584-8539(95)01421-P . Retrieved 2 January 2024.
  23. "Absorption and fluorescence properties of fluorescein". scholar.google.com. Retrieved 2023-12-28.
  24. 1 2 3 4 5 danielduran.cz, Design: Martin Kolerus, Code: Daniel Duran. "prof. Dr. Mikael Kubista, Ph.D." biocev.eu. Biocev. Retrieved 2023-12-28.{{cite web}}: CS1 maint: multiple names: authors list (link)
  25. "DNA tetraplex formation in the control region of c-my". academic. Retrieved 2 January 2024.
  26. "Light-up probes: thiazole orange-conjugated peptide nucleic acid for detection of target nucleic acid in homogeneous solution". scholar.google.com. Retrieved 2023-12-28.
  27. Svanvik, Nicke; Westman, Gunnar; Wang, Dongyuan; Kubista, Mikael (2000). "Light-Up Probes: Thiazole Orange-Conjugated Peptide Nucleic Acid for Detection of Target Nucleic Acid in Homogeneous Solution". Analytical Biochemistry. 281 (1): 26–35. doi:10.1006/abio.2000.4534. PMID   10847607 . Retrieved 2 January 2024.
  28. Bengtsson, M.; Ståhlberg, A.; Rorsman, P.; Kubista, M. (2005). "Gene expression profiling in single cells from the pancreatic islets of Langerhans reveals lognormal distribution of mRNA levels". Genome Research. 15 (10): 1388–1392. doi:10.1101/gr.3820805. PMC   1240081 . PMID   16204192 . Retrieved 2 January 2024.
  29. "Horizontal transfer of whole mitochondria restores tumorigenic potential in mitochondrial DNA-deficient cancer cells". scholar.google.com. Retrieved 2023-12-28.
  30. "Highly Ranked Scholars™ 2022". scholargps.com. Retrieved 27 May 2024.
  31. "ORCID". orcid.org. Retrieved 2023-12-28.